glp-1 drugs pharmaceutical companies 2025 Market Trends and Global Forecasts Report 2025: A GLP-1 Receptor Agonist Market Size
Description
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial
doi:10.1016/j.bbr.2019.112359 84
GLP-1RA, Glucagon-like peptide-1 receptor agonists
Crump, C
